Literature DB >> 20191660

Attention deficit hyperactivity disorder: concordance of the adolescent version of the Composite International Diagnostic Interview Version 3.0 (CIDI) with the K-SADS in the US National Comorbidity Survey Replication Adolescent (NCS-A) supplement.

Jennifer Greif Green1, Shelli Avenevoli, Matthew Finkelman, Michael J Gruber, Ronald C Kessler, Kathleen R Merikangas, Nancy A Sampson, Alan M Zaslavsky.   

Abstract

This paper evaluates the internal consistency reliability and concurrent validity of the assessment of Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) attention deficit hyperactivity disorder (ADHD) in the adolescent version of the World Health Organization (WHO) Composite International Diagnostic Interview Version 3.0 (CIDI). The CIDI is a lay-administered diagnostic interview that was carried out in conjunction with the US National Comorbidity Survey Adolescent Supplement, a US nationally representative survey of 10,148 adolescents and their parents. Internal consistency reliability was evaluated using factor and item response theory analyses. Concurrent validity was evaluated against diagnoses based on blinded clinician-administered interviews. Inattention and hyperactivity-impulsivity items loaded on separate but correlated factors, with hyperactivity and impulsivity items forming a single factor in parent reports but separate factors in youth reports. We were able to differentiate hyperactivity and impulsivity factors for parents as well by eliminating a subset who endorsed zero ADHD items from the factor analysis. Although concurrent validity was relatively weak, decomposition showed that this was due to low validity of adolescent reports. A modified CIDI diagnosis based exclusively on parent reports generated a diagnosis that had good concordance with clinical diagnoses [area under the curve (AUC) = 0.78]. Implications for assessing ADHD using the CIDI and the effect of different informants on measurement are discussed. Copyright 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20191660      PMCID: PMC2938790          DOI: 10.1002/mpr.303

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  27 in total

Review 1.  Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics.

Authors: 
Journal:  Pediatrics       Date:  2000-05       Impact factor: 7.124

2.  Measures of clinical significance.

Authors:  Helena Chmura Kraemer; George A Morgan; Nancy L Leech; Jeffrey A Gliner; Jerry J Vaske; Robert J Harmon
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-12       Impact factor: 8.829

3.  A population-based twin study of major depression in women. The impact of varying definitions of illness.

Authors:  K S Kendler; M C Neale; R C Kessler; A C Heath; L J Eaves
Journal:  Arch Gen Psychiatry       Date:  1992-04

Review 4.  Evaluating the evidence for and against the overdiagnosis of ADHD.

Authors:  Mark J Sciutto; Miriam Eisenberg
Journal:  J Atten Disord       Date:  2007-09       Impact factor: 3.256

5.  ADHD and college students: exploratory and confirmatory factor structures with student and parent data.

Authors:  Joseph J Glutting; Eric A Youngstrom; Marley W Watkins
Journal:  Psychol Assess       Date:  2005-03

6.  Diagnostic agreement between clinicians and the Diagnostic Interview for Children and Adolescents--DICA-R--in an outpatient sample.

Authors:  L Ezpeleta; N de la Osa; J M Doménech; J B Navarro; J M Losilla; J Júdez
Journal:  J Child Psychol Psychiatry       Date:  1997-05       Impact factor: 8.982

Review 7.  Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents.

Authors:  William E Pelham; Gregory A Fabiano; Greta M Massetti
Journal:  J Clin Child Adolesc Psychol       Date:  2005-09

8.  The National Comorbidity Survey Replication (NCS-R): background and aims.

Authors:  Ronald C Kessler; Kathleen R Merikangas
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

Review 9.  Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder.

Authors:  Brent R Collett; Jeneva L Ohan; Kathleen M Myers
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-09       Impact factor: 8.829

10.  National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessments.

Authors:  Ronald C Kessler; Shelli Avenevoli; Jennifer Green; Michael J Gruber; Margaret Guyer; Yulei He; Robert Jin; Joan Kaufman; Nancy A Sampson; Alan M Zaslavsky; Kathleen R Merikangas
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-04       Impact factor: 8.829

View more
  19 in total

1.  Validation of diagnoses of distress disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A).

Authors:  Jennifer Greif Green; Shelli Avenevoli; Michael J Gruber; Ronald C Kessler; Matthew D Lakoma; Kathleen Ries Merikangas; Nancy A Sampson; Alan M Zaslavsky
Journal:  Int J Methods Psychiatr Res       Date:  2011-11-15       Impact factor: 4.035

2.  Shyness versus social phobia in US youth.

Authors:  Marcy Burstein; Leila Ameli-Grillon; Kathleen R Merikangas
Journal:  Pediatrics       Date:  2011-10-17       Impact factor: 7.124

3.  Validation of the diagnoses of panic disorder and phobic disorders in the US National Comorbidity Survey Replication Adolescent (NCS-A) supplement.

Authors:  Jennifer Greif Green; Shelli Avenevoli; Matthew Finkelman; Michael J Gruber; Ronald C Kessler; Kathleen R Merikangas; Nancy A Sampson; Alan M Zaslavsky
Journal:  Int J Methods Psychiatr Res       Date:  2011-06       Impact factor: 4.035

4.  Diagnostic validity across racial and ethnic groups in the assessment of adolescent DSM-IV disorders.

Authors:  Jennifer Greif Green; Michael J Gruber; Ronald C Kessler; Julia Y Lin; Katie A McLaughlin; Nancy A Sampson; Alan M Zaslavsky; Margarita Alegria
Journal:  Int J Methods Psychiatr Res       Date:  2012-11-13       Impact factor: 4.035

5.  A zero- and K-inflated mixture model for health questionnaire data.

Authors:  Matthew D Finkelman; Jennifer Greif Green; Michael J Gruber; Alan M Zaslavsky
Journal:  Stat Med       Date:  2011-03-01       Impact factor: 2.373

6.  Associations of Sociodemographic Factors and Psychiatric Disorders With Type of School-Based Mental Health Services Received by Youth.

Authors:  Jennifer Greif Green; Katie A McLaughlin; Margarita Alegría; Elizabeth Bettini; Michael Gruber; Kimberly Hoagwood; Lana Le Tai; Nancy Sampson; Alan M Zaslavsky; Ziming Xuan; Ronald C Kessler
Journal:  J Adolesc Health       Date:  2020-04-18       Impact factor: 5.012

7.  Mental health service use among high school students exposed to interpersonal violence.

Authors:  Jennifer Greif Green; Renee M Johnson; Erin C Dunn; Michael Lindsey; Ziming Xuan; Alan M Zaslavsky
Journal:  J Sch Health       Date:  2014-02       Impact factor: 2.118

8.  Parenting style and mental disorders in a nationally representative sample of US adolescents.

Authors:  John David Eun; Diana Paksarian; Jian-Ping He; Kathleen Ries Merikangas
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-11-06       Impact factor: 4.328

9.  Neighborhood sociodemographic predictors of Serious Emotional Disturbance (SED) in schools: demonstrating a small area estimation method in the National Comorbidity Survey (NCS-A) Adolescent Supplement.

Authors:  Jennifer Greif Green; Margarita Alegría; Ronald C Kessler; Katie A McLaughlin; Michael J Gruber; Nancy A Sampson; Alan M Zaslavsky
Journal:  Adm Policy Ment Health       Date:  2015-01

10.  Disruptive Mood Dysregulation Disorder at Ages 13-18: Results from the National Comorbidity Survey-Adolescent Supplement.

Authors:  Robert R Althoff; Eileen T Crehan; Jian-Ping He; Marcy Burstein; James J Hudziak; Kathleen R Merikangas
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-01-15       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.